Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CareRxTSX:CRRX +0.60%66 Market Cap is C$213.8 Mil as of Aug. 09, 2026. GuruFocus rates TSX:CRRX with a GF Score™ of 66/100 and a GF Value™ of C$2.28 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 690 Healthcare Providers & Services companies, CareRx ranks better than 55.07% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). CareRx's share price for the quarter that ended in Jun. 2026 was C$3.46. CareRx's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 63.4 Mil. Therefore, CareRx's market cap for the quarter that ended in Jun. 2026 was C$219.5 Mil.
CareRx's quarterly market cap
declined
from Dec. 2025 (C$239.8 Mil) to Mar. 2026 (C$235.6 Mil) and
declined
from Mar. 2026 (C$235.6 Mil) to Jun. 2026 (C$219.5 Mil).
CareRx's annual market cap
increased
from Dec. 2023 (C$96.3 Mil) to Dec. 2024 (C$128.0 Mil) and
increased
from Dec. 2024 (C$128.0 Mil) to Dec. 2025 (C$239.8 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. CareRx's Enterprise Value for Today is C$280.6 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
CareRx Market Cap Related Terms
CareRx Market Cap Historical Data
* Premium members only.
The historical data trend for CareRx's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, CareRx's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CareRx Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CareRx's Market Cap distribution charts can be found below:
* The bar in red indicates where CareRx's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
CareRx's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CareRx (TSX:CRRX) has a Market Cap of C$213.8 Mil as of Aug. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CareRx and its competitors. According to the industry distribution chart, CareRx ranks #310 out of 690 companies in the Healthcare Providers & Services industry, placing it in the top 44.9%.
Is CareRx's Market Cap too high?
CareRx's current Market Cap is C$213.8 Mil. Based on the distribution chart, CareRx ranks #310 out of 690 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, CareRx has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does CareRx's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, CareRx ranks #310 out of 690 companies for Market Cap. This puts CareRx in the upper half of its industry. The industry median Market Cap is 104.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 104.56, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on CareRx and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 104.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CareRx's current Market Cap is C$213.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CareRx stock overvalued right now?
Based on GuruFocus' analysis, CareRx (TSX:CRRX) is currently considered Significantly Overvalued. The stock's GF Value™ is C$2.28, compared to a current price of C$3.37 — trading 47.8% above its estimated fair value. The current Market Cap is C$213.8 Mil. CareRx's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For CareRx (TSX:CRRX), the current Market Cap is C$213.8 Mil as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CareRx (TSX:CRRX) Overvalued in 2026?
Based on GuruFocus' analysis, CareRx stock appears to be overvalued.
The current stock price of C$3.37 is trading 47.8% above its estimated GF Value™ of C$2.28.
GuruFocus considers CareRx to be Significantly Overvalued.
Key valuation signals for TSX:CRRX:
Market Cap: C$213.8 Mil
GF Value™: C$2.28 vs. price of C$3.37 (47.8% above fair value)
No single metric tells the full story. See the TSX:CRRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CareRx Corp is a provider of specialty pharmacy services to seniors. The company is a national organization with a large network of pharmacy fulfilment centers strategically located across the country. This allows it to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. It takes an active role in working with its home operator partners to promote resident health, staff education and medication system quality and efficiency. The Company has one reportable segment which consists of the Company-owned and operated institutional pharmacy business. Geographically it derives revenue from the sales of goods and capitated service fees in Ontario and Western Canada.
66GF Score
Get the complete analysis for TSX:CRRX
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSX:CRRX has been successfully added to your 
